Patent assignee · US · COMPANY

Applied Immune Sciences, Inc.

🏢 View company profile →
12Patents
0Active
12Granted
30Portfolio score

Filing activity: Feb 22, 1983 → Jun 6, 1995

Most-cited patents

PatentTitleAreaCited byStatus
US5173414A Production of recombinant adeno-associated virus vectors Chemistry; Metallurgy 322 Expired
US5691176A Recombinant adeno-associated virus vector packaging cells and methods for use Chemistry; Metallurgy 83 Expired
US5354678A Production of recombinant adeno-associated virus vectors Chemistry; Metallurgy 78 Expired
US5523096A Removal of selected factors from whole blood or its components Human Necessities 50 Expired
US5437861A Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome Emerging Cross-Sectional Technologies 46 Expired
US4540401A In vivo therapeutic apheresis using lipid vesicles Human Necessities 45 Expired
US5241012A Activated and conjugated polystyrene substrate Emerging Cross-Sectional Technologies 30 Expired
US5283034A Stabilization of sterilized surfaces for research and medical use Chemistry; Metallurgy 28 Expired
US5681731A Method for producing recombinant adeno-associated virus vectors Chemistry; Metallurgy 27 Expired
US5286789A Solid phase multiple peptide synthesis Emerging Cross-Sectional Technologies 4 Expired
US5484852A Activated and conjugated polystyrene substrate Emerging Cross-Sectional Technologies 1 Expired
US5317088A C-terminal conglutinin fragments coupled to solid support Human Necessities 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.